Dr. Devang Thakor

Anioplex, LLC
President

Devang Thakor runs Anioplex, LLC, a global strategy, business, and technical advisory in Silicon Valley serving startups, multinational corporations, venture capital firms, and universities. Previously, he developed gene therapy, stem cell, and biomaterial technologies and their applications to chronic pain and spinal cord injury at Kyoto University and Harvard Medical School, where his work was featured in leading journals such as PNAS, Biomaterials, and Molecular Therapy. Devang received his Ph.D. in Biomedical Engineering from UCLA and is currently studying law at Santa Clara University, where he expects to receive his J.D. in 2020.